2. BIS (2009): Life Sciences Blueprint The life sciences industry, comprising pharmaceuticals, medical biotechnology and medical technology, is one industry where we are world-class, and have the potential to go further. A strong life sciences industry can drive growth and high-value job creation as well as playing a vital role in meeting future healthcare challenges. www.nic.nhs.uk
4. NIC Innovation Development Model Reactive Approach: An ‘always open’ door for innovators to share their ideas with the NHS and receive guidance and other support. Proactive Approach: An ‘always open’ door for frontline NHS staff and patients to articulate perceived needs, and for innovators to compete and win contracts to create solutions. Online Scorecard Deeper Due Diligence REACTIVE EXPERT GROUPS Healthcare KTN Clinical LeadsRoyal Colleges Key Trusts TSB NERACD&BCharities Online Innovation Showcase Information Diffusion Online Project ZoneOpen Innovation & Project Mgt Wouldn’t it be great if? workshops PROACTIVE Validation of Need Online Competition Tool Online SOCNPublish Need Online Statement of Clinical Need
5. NIC Programmes Needs In conjunction with The Technology Strategy Board and Knowledge Transfer Networks, NIC has developed a Statement of Clinical Needs online tool which provides a forum for clinicians to express what they need. Benefits: The information helps industry understand the clinical needs of the NHS, and what innovations they can either mobilise or develop to meet these needs. Creates an alignment with clinical demand and focussed industry supply. Stakeholders benefit from knowing what frontline clinicians are saying needs to be addressed. Next Steps: Partnership programme with NHS Networks. NHS Networks has rich, varied and vibrant networks that could be a valuable source of identifying genuine and real time frontline needs and subsequently provide a forum for the NHS community to share knowledge and ideas to meet these needs and prepare channels for diffusion. Facilitating a joint needs and innovation development programme with all AHSCs.
6. NIC Programmes Solutions NIC has developed a portfolio of pre-commercial procurement tools to speed the development of innovative solutions. TheScorecard is essentially the ‘first interview’ with an innovator from an IP, need, benefits perspective and explores what assistance the innovator needs to deliver the idea. The Competition Tool is an easy-to-use resource to commission the development of solutions. Benefits: Open, fair and transparent processes that speed development of innovations. Next Steps: Continue to support NHS Supply Chain, Technology Strategy Board. Continue to work with The Department for Business to roll out tools across Government.
7. NIC Programmes Recent Network Developments Facilitating and supporting a joint initiative with all the AHSCS to collaborate and develop solutions to areas of unmet clinical need. Working with sector specific bodies such as NHS Blood & Transplant and Ambulance service to develop innovations to fulfil unmet needs. Working with SME’s & Charities to develop innovations to meet articulated unmet needs in paediatric care.
8. Does this model work? Potential £160m p/a saving Potential £30m p/a saving £4000 per HCAI avoided
9.
10.
11.
12.
13.
14.
15.
16. Linked Data Open Health Innovation Ontology (OHIO) Formal representation of a domain (i.e. health technology innovation) Models concepts and relationships Shared conceptualisation Used to reason within domain Enabled by Web3 resources: e.g. RDFa, OWL Semantically-enhanced Applications Potential to save time, money Infers meaning : ‘connecting-the-data’ to derive meaning Web 2 (social networking features) combined with Web 3 (semantic) has great potential to advance performance in innovation development
22. Economic BenefitsFinancial Year 2009/10 Value to UK PLC: The NIC supports SME’s to develop innovative solutions to patient and staff needs. With the support of the NIC, a number of innovations have been able to attract significant funding. NIC’s support has also contributed to the value of UK Plc by helping to attract funding to the value of £290m. Potential Value to NHS: The NIC has supported the development of innovations that would improve the quality of the patient experience and generate potentially significant cost savings to the NHS.